Table 1 Demographic data of patient groups with mild, moderate, and severe COVID-19 manifestations and control subjects
From: Vitamin D assessment in patients with COVID-19 virus and correlation with severity
| Â | Mild n=20 | Moderate n=20 | Severe n=20 | Control n=20 | P value | |
|---|---|---|---|---|---|---|
Age (years) (Mean ±SD) | 55.400 ±16.791 | 59.550 ±13.953 | 62.750 ±15.003 | 25.700 ±3.197 | <0.001 | |
Sex (n, %) | Male | 13 (65%) | 9 (45%) | 13 (65%) | 11 (55%) | 0.522 |
Female | 7 (35%) | 11 (55%) | 7 (35%) | 9 (45%) | ||
Smoking (n, %) | Smokers | 13 (65%) | 16 (80%) | 10 (50%) | 18 (90%) | 0.030 |
Non-smokers | 7 (35%) | 4 (20%) | 10 (50%) | 2 (10%) | ||
Medical history (n, %) | Free | 9 (45%) | 3 (15%) | 5 (25%) | 20 (100%) | <0.001 |
HTN | 6 (30%) | 6 (30%) | 6 (30%) | 0 | ||
DM | 2 (10%) | 5 (25%) | 0 | 0 | ||
AF+HTN | 0 | 2 (10%) | 1 (5%) | 0 | ||
DM+HTN | 3 (15%) | 4 (20%) | 8 (40%) | 0 | ||